Biotechnology
ABVX
10.55
price up icon2.73%   0.28
after-market Handel nachbörslich: 10.55

Abivax Adr (ABVX)
full-star
loading
Überblick Nachrichten Preisverlauf Forum Prognose
Schlusskurs vom Vortag:
$10.27
Offen:
$10.41
24-Stunden-Volumen:
33,187
Relative Volume:
0.28
Marktkapitalisierung:
$654.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-159.39M
KGV:
-
EPS:
-
Netto-Cashflow:
$-105.22M
1W Leistung:
-1.31%
1M Leistung:
+7.87%
6M Leistung:
-27.44%
1J Leistung:
+4.46%
1-Tages-Spanne:
Value
$10.25
$11.02
1-Wochen-Bereich:
Value
$10.21
$11.02
52-Wochen-Spanne:
Value
$8.75
$17.02

Abivax Adr Stock (ABVX) Company Profile

Name
Firmenname
Abivax Adr
Name
Sektor
Healthcare (1180)
Name
Branche
Biotechnology (680)
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
61
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ABVX's Discussions on Twitter

Abivax Adr Stock (ABVX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-11-14 Eingeleitet Leerink Partners Outperform
2023-11-14 Eingeleitet Morgan Stanley Equal-Weight

Abivax Adr Aktie (ABVX) Neueste Nachrichten

pulisher
Oct 15, 2024

Check Out Abivax ADR (ABVX)’s Trade Data Rather Than the Analysts’ Views - SETE News

Oct 15, 2024
pulisher
Oct 15, 2024

Insider’s View: Deciphering Abivax ADR (ABVX)’s Financial Health Through Ratios - The Dwinnex

Oct 15, 2024
pulisher
Oct 07, 2024

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation - GlobeNewswire Inc.

Oct 07, 2024
pulisher
Sep 26, 2024

Abivax SA Unveils New Ulcerative Colitis Treatment Data - TipRanks

Sep 26, 2024
pulisher
Sep 25, 2024

Abivax Reports Progress in Ulcerative Colitis Therapy - TipRanks

Sep 25, 2024
pulisher
Sep 16, 2024

DEADLINE ALERT for ABR, FIVE, DXC, and INDV: The Law - GlobeNewswire

Sep 16, 2024
pulisher
Sep 14, 2024

Wall Street Analysts Believe Abivax SA Sponsored ADR (ABVX) Could Rally 193.62%: Here's is How to Trade - MSN

Sep 14, 2024
pulisher
Sep 13, 2024

Is Abivax SA Sponsored ADR (ABVX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Sep 13, 2024
pulisher
Sep 09, 2024

Abivax SA Details Financial Struggles and Advances - TipRanks

Sep 09, 2024
pulisher
Sep 09, 2024

Abivax SA Reveals Soaring R&D Costs in H1 2024 - TipRanks

Sep 09, 2024
pulisher
Jul 15, 2024

Inflammatory Bowel Disease Treatment Market Size Expected to Reach USD 33.19 Bn by 2032 - GlobeNewswire Inc.

Jul 15, 2024
pulisher
Jun 04, 2024

Abivax SA Advances with Positive Trial OutcomesTipRanks.com - TipRanks

Jun 04, 2024
pulisher
May 07, 2024

Abivax SA Announces Upcoming General MeetingTipRanks.com - TipRanks

May 07, 2024
pulisher
Apr 29, 2024

Guggenheim starts Abivax stock with Buy, cites promising ulcerative colitis drug By Investing.com - Investing.com

Apr 29, 2024
pulisher
Apr 02, 2024

Abivax SA Secures Funding and Expands Operations - TipRanks

Apr 02, 2024
pulisher
Oct 26, 2023

Citi Appointed as Depositary Bank for Abivax SA's ADR Program - Business Wire

Oct 26, 2023

Finanzdaten der Abivax Adr-Aktie (ABVX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie ABVX

biotechnology SMMT
$19.96
price up icon 5.11%
biotechnology INCY
$75.75
price down icon 0.50%
biotechnology UTHR
$376.80
price up icon 0.74%
biotechnology MRNA
$53.54
price down icon 2.00%
biotechnology BGNE
$207.25
price up icon 1.49%
biotechnology BNTX
$108.97
price down icon 2.25%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | Open in MarketWatch | Open in EDGAR | Open in Reuters
Kapitalisierung:     |  Volumen (24h):